Shalby Q4 FY26: Profit ₹18.32 cr, sales up 9%

Key takeaway from Shalby’s March 2026 results

Shalby Limited reported a turnaround in profitability in the quarter ended March 2026, supported by higher operating profit and modest revenue growth. The hospital operator posted a consolidated net profit of ₹18.32 crore for the March 2026 quarter, compared with a net loss of ₹11.02 crore in the March 2025 quarter. Revenue for the quarter increased to ₹287.45 crore from ₹264.89 crore a year earlier, translating into an 8.52% rise.

For the full year ended March 2026, Shalby reported consolidated net profit of ₹37.39 crore, up 501.13% from ₹6.22 crore in the previous year ended March 2025. Full-year sales rose 5.01% to ₹1,141.43 crore compared with ₹1,086.96 crore in the year ended March 2025.

What Reuters highlighted on May 27

A Reuters item dated May 27 flagged the company’s March-quarter consolidated net profit at 183.2 million rupees. In normalized terms, this is about ₹18.32 crore, aligning with the quarterly profit number reported in the company’s results summary. Reuters also referenced the year-on-year comparison, showing the March 2026 quarter swung to profit from a loss in the corresponding period last year.

Quarter performance: revenue up, profit turns positive

In the March 2026 quarter, Shalby’s sales increased by 8.52% to ₹287.45 crore. Alongside revenue growth, operating profitability improved. Operating profit margin (OPM) was reported at 10.21% for the quarter, up from 7.87% in the March 2025 quarter.

Operating performance also reflected in earnings before tax measures. Profit before depreciation and tax (PBDT) rose to ₹28.09 crore from ₹15.49 crore, a year-on-year increase of 81%. Profit before tax (PBT) stood at ₹9.61 crore versus a loss before tax of ₹0.74 crore in the March 2025 quarter. Net profit for the quarter came in at ₹18.32 crore versus the ₹11.02 crore loss a year earlier.

Full-year FY26: strong profit growth on steady sales

For the year ended March 2026, Shalby’s sales climbed 5.01% to ₹1,141.43 crore, compared with ₹1,086.96 crore in the prior year. While revenue growth remained in the mid-single digits, profitability expanded sharply in percentage terms because the base was low.

The company reported full-year net profit of ₹37.39 crore, up from ₹6.22 crore in the year ended March 2025. Operating profit margin for the full year stood at 12.51% compared with 12.20% in the previous year, indicating a slight improvement in operating efficiency. Full-year PBDT was ₹130.55 crore versus ₹121.49 crore, while full-year PBT rose to ₹60.56 crore from ₹55.73 crore.

Reported numbers in rupees and crores

The company’s quarterly sales were also presented as ₹2,874.45 million for March 2026 versus ₹2,648.92 million a year earlier. Normalized to the same base unit used across this report, those figures correspond to ₹287.45 crore and ₹264.89 crore, respectively.

Net income was stated as ₹183.18 million in the March 2026 quarter compared with a net loss of ₹110.15 million a year ago. In ₹ crore terms, this is a profit of ₹18.32 crore versus a loss of ₹11.02 crore.

Consolidated summary table (₹ crore)

Note: “LP” denotes a shift from loss to profit, as presented in the results summary.

How market participants may read the results

The March 2026 quarter stands out mainly for the profit turnaround versus the year-ago period, alongside an improvement in operating margin. For investors tracking hospital operators, changes in operating margin and the move from losses to profits are often watched as indicators of cost control and operating leverage.

At the same time, the top-line trend in the reported numbers is steady rather than sharp, with quarterly sales rising 8.52% and full-year sales rising 5.01%. That combination, steady revenue growth with improved operating margins, explains much of the change in earnings metrics reported for the period.

Additional data points cited by market trackers

A market tracker update (last updated May 28, 2026) listed Shalby’s net profit for the Mar 2026 quarter at ₹18.45 crore and compared it with ₹1.28 crore for the Dec 2025 quarter. The same source also stated a -0.13% change figure alongside the March-quarter net profit entry.

These tracker figures are separate from the consolidated results summary in the earnings release excerpt, which reported March-quarter net profit at ₹18.32 crore and highlighted year-on-year movement from loss to profit.

Why the FY26 print matters

The FY26 numbers provide a clearer picture than a single quarter because they smooth out period-specific swings. In Shalby’s case, FY26 net profit of ₹37.39 crore against ₹6.22 crore in FY25 shows how quickly profitability can change when operating performance improves off a lower base.

Operating profit margin at 12.51% for the year, slightly higher than 12.20% in FY25, also suggests that the profit improvement was not driven only by one-off factors in the period summary provided. But readers should focus on the reported metrics and their movement across periods, since no additional management commentary or drivers were included in the provided text.

What to watch next

The results set a benchmark for how Shalby begins FY27, particularly on sustaining operating margins and translating revenue growth into net profit. The next earnings update, once reported, will help investors assess whether the March-quarter improvement is maintained across subsequent quarters.